Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
Meningioma (MGM) is the most common type of intracranial tumor in adults. The validation of novel prognostic biomarkers to better inform tumor stratification and clinical prognosis is urgently needed. Many molecular and cellular alterations have been described in MGM tumors over the past few years,...
Saved in:
Main Authors: | Rafael Roesler, Barbara Kunzler Souza, Gustavo R. Isolan |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cf5a5bd28c35447baf38e34d1f7122fc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma
by: Kustic,Domagoj, et al.
Published: (2019) -
Relación entre la amplificación del oncogén C-erbB-2 y parámetros histológicos con sobrevida libre de enfermedad en pacientes con cáncer de mama
by: Rojas-Atencio,Alicia E., et al.
Published: (2005) -
Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs
by: Louise Pinet, et al.
Published: (2021) -
Isolated Intraconal Meningioma
by: Mohammad Taher Rajabi, et al.
Published: (2021) -
Surgical Management of Intracranial Meningiomas in the Elderly: Early and Long-term Outcomes
by: Czernicki T
Published: (2020)